phactMI: Delivering accurate drug information to point of care

Pharma R&D Today

Physicians, nurse practitioners and pharmacy staff members demonstrate an incredible knowledge of drugs, built up through many years of point-of-care experience. This knowledge informs their clinical decisions.

phactMI: Delivering accurate drug information to point of care

Pharma R&D Today

Physicians, nurse practitioners and pharmacy staff members demonstrate an incredible knowledge of drugs, built up through many years of point-of-care experience. This knowledge informs their clinical decisions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

3 Ways to Fast Track Your Career in Clinical Research

XTalks

If you’ve spent some time working as a clinical research associate (CRA) and are looking to advance your career, you might be wondering where to start. Here are three ways to advance your career in clinical research. RELATED: Clinical Research Jobs: How to Choose the Right Career Path.

18 products ALTERNATIVE to PARACETAMOL

Druggist

200mg ibuprofen is widely available in shops and pharmacies for self-selection by customers. 400mg ibuprofen, on the other hand, is a pharmacy-only medication (P), which means it can only be purchased from registered pharmacies. . Day and Night Nurse.

Trans Healthcare: How Pharma Marketers Can Positively Impact This Underserved Community

Intouch Solutions

It, like the Nightingale Pledge for nurses, is a list of tenets that physicians abide by to uphold certain morals and to ensure healthcare professionals (HCPs) provide top-quality care to all who seek it. “I Download the PDF. “I

Best Toenail Fungus Treatment Products

Druggist

The main products used for toenail fungus treatment are available in most pharmacies, supermarkets and perhaps with the best range of products found online. It is advertised as effectively and clinically proven product with easy daily applications which last less than one minute.

RECOVERY Trial Data Monitoring Committee Recommends Continuing Evaluation of REGN-COV2 in All Hospitalized Patients

The Pharma Data

Regeneron announced today an update from the independent data monitoring committee (DMC) for the United Kingdom-based RECOVERY trial evaluating REGN-COV2 in hospitalized patients with COVID-19.

Ep. 003 – Ritesh Patel Podcast Transcript

Pharma Marketing Network

And it’s the first time I’m seeing our friends on the clinical side of the business out innovating the commercial side of the business in pharma. Novartis, Boehringer, Pfizer are all on the clinical side really chasing the innovations around R&D. Most recently, telemedicine and specialty pharmacy connected together to create a product that a consumer can get directly. or change the way I do clinical trials or change the way I actually do clinical recruitment?

How the UAE’s COVID-19 Vaccination Strategy Differs from North America’s and Why It Matters

XTalks

Bal’awi, a senior clinical lecturer at The University of Petra, Jordan, and consultant pharmacotherapist of infectious diseases, about the public’s opinion of COVID-19 vaccines. The new vaccine technology (mRNA) has been in research since 2005, but in trials on cancer cells.

Regeneron’s Casirivimab and Imdevimab Antibody Cocktail for COVID-19 is First Combination Therapy to Receive FDA Emergency Use Authorization

The Pharma Data

The clinical evidence from Regeneron’s outpatient trial suggests that monoclonal antibodies such as casirivimab and imdevimab have the greatest benefit when given early after diagnosis and in patients who have not yet mounted their own immune response or who have high viral load.

Regeneron Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial in Hospitalized Patients on Low-flow Oxygen

The Pharma Data

As in earlier outpatient trial, immune status when patients entered the trial was a strong predictor of viral load and clinical outcomes. Similar clinical and virologic efficacy was observed for the high and low doses of the antibody cocktail. TARRYTOWN, N.Y. ,

HR 52

Tampa General Hospital is First in Florida To Offer Monoclonal Antibody Treatments to COVID-19 Patients

The Pharma Data

“Tampa General Hospital and USF Health were already actively conducting clinical trials on COVID-19 and had the team, location and infrastructure in place to identify and care for the patients who can benefit most from this treatment.” Tampa Bay residents also receive world-class care from the TGH Urgent Care powered by Fast Track network of clinics, and they can even receive home visits in select areas through TGH Urgent Care at Home, powered by Fast Track.

Regeneron Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses

The Pharma Data

“Patients in our antibody cocktail outpatient clinical trial experienced significant reductions in virus levels and required fewer medical visits for COVID-19, suggesting the therapy can help reduce the current burden on hospitals and healthcare systems,” said George D.

Regeneron’s REGEN-COV2 is First Antibody Cocktail for COVID-19 to Receive FDA Emergency Use Authorization

The Pharma Data

The clinical evidence from Regeneron’s outpatient trial suggests that monoclonal antibodies such as REGEN-COV2 have the greatest benefit when given early after diagnosis and in patients who have not yet mounted their own immune response or who have high viral load. We are encouraged that no variants resistant to the cocktail were identified in the clinical trial analyses to date, which is consistent with our preclinical findings. TARRYTOWN, N.Y. ,

New England Journal of Medicine Publishes Positive Initial Regeneron Antibody Cocktail Results in Non-hospitalized Patients with COVID-19

The Pharma Data

NASDAQ: REGN ) today announced that the New England Journal of Medicine (NEJM) has published initial clinical data from an ongoing seamless Phase 1/2/3 trial of the antibody cocktail casirivimab and imdevimab in non-hospitalized patients with COVID-19. TARRYTOWN, N.Y. ,

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

So for example, you think about the doctors and nurses that you know, are they getting paid far more than they were, you know, five ten twenty years ago now, I mean, maybe it’s growing at the rate of inflation and there’s really two markets now particularly because of high deductible plans and the high prices in healthcare. Don (PMN): The specialty pharmacy. Dave (HR): Oh, no, I think the Specialty Pharmacy. I mean Mayo Clinic, they found about 20% misdiagnosis.

HR 40

COVID-19 Pandemic Coverage

XTalks

By the end of August, the World Health Organization (WHO) counted 33 vaccine candidates in some stage of clinical trial evaluation. Merck is a bit of a dark horse in the COVID-19 race, announcing it will begin its human trials of a candidate vaccine only in mid-August.